Factors associated with HIV viral suppression among adolescents in Kabale district, South Western Uganda.

BACKGROUND: The goal of antiretroviral therapy is to achieve sustained human immune deficiency virus (HIV) viral suppression. However, research on factors associated with viral load suppression among adolescents in low and middle-income countries is limited. The objectives of this study were to determine HIV viral suppression levels among adolescents in Kabale district and the associated clinical, adherence and psychosocial factors.
METHODS: Cross-sectional and retrospective cohort study designs were used. Two hundred and forty-nine adolescents living with HIV that attended clinics between September and October 2019 at nine health facilities were interviewed and their medical records reviewed. A data abstraction tool was used to collect clinical data from adolescent's clinical charts, face to face interviews were conducted using semi-structured questionnaire adopted from the HEADS tool and in-depth interviews conducted with ten key informants. Qualitative data was analyzed using thematic content analysis. Logistic regression was used to determine the magnitude by which clinical and psychosocial factors influence viral load suppression. Odds Ratios (ORs) were used for statistical associations at 95% confidence interval considering statistical significance for p-values less than 0.05. Qualitative data collected from Key informants to support our quantitative findings was analyzed using thematic content analysis.
RESULTS: HIV viral suppression among (n = 249) adolescents was at 81%. Having no severe opportunistic infections was associated with viral load suppression among adolescent living with HIV (OR = 1.09; 95%CI [1.753-4.589]; p<0.001) as well as having no treatment interruptions (OR = 0.86; 95% CI [2.414-6.790]; p = 0.004). Belonging to a support group (OR = 1.01; 95% CI [1.53-4.88]; P = 0.020), having parents alive (OR = 2.04; 95% CI[1.02-4.12]; P = 0.047) and having meals in a day (OR = 5.68; C.I = 2.38-6.12, P = 0.010), were significantly associated to viral load suppression. The findings also indicated that long distances from health facilities, transport challenges and unprofessional conduct of health workers that make adolescent unwelcome at health facilities negatively affected viral suppression among adolescents.
CONCLUSION: The findings indicate that HIV viral suppression among adolescents on ART was at 81%. Kabale district was likely not to achieve the third 90 of the UNAIDS 90-90-90 global target for this population category. The findings further indicate that having no severe opportunistic infection and no treatment interruptions, good nutrition status, peer support and support from significant others, were highly associated with viral load suppression.

Background

Adolescents and young people represent a growing number of people living with HIV worldwide [1]. The mortality of adolescents living with HIV due to acquired immune deficiency syndrome (AIDS)-related causes is higher than in adults [2]. Globally, up to 150 adolescents die every day due to AIDS-related illnesses [3]. In 2016, 91% of adolescent deaths worldwide were reported in sub-Saharan Africa, and the rate of AIDS-related deaths among this age group had not reduced [1]. In addition, by 2018 children and adolescents from different parts of the world had worse viral suppression outcomes than adults [4].

The goal of ART is to achieve a sustained suppression of HIV replication. World Health Organization (WHO) recommends individual-level viral load as a measure of ART efficacy and treatment adherence. According to [5], treatment success is defined as a viral load threshold of <1000 copies/mL. Viral suppression is also one of the 10 global indicators in the 2015 WHO consolidated strategic information guidelines for HIV in the health sector [6]. Majority of previous studies on adolescents have been carried out in the United States and it is possible that these findings cannot be extrapolated to the African setting [7].

In 2014, the UNAIDS launched a global response toward achieving “the third 90” in the 90-90-90 targets, an initiative to end the AIDS epidemic as a public health threat by 2030 [6]. The UNAIDS’ 90-90-90 campaign aims to have 90% of people living with HIV to know their status, have 90% of people living with HIV who know their status start or maintain their treatment, and have 90% of people on ART to be virally suppressed by 2020. High rates of viral suppression are attainable at the community and country level and studies have identified numerous individuals, interpersonal, and institutional factors that are associated with viral suppression in general population samples [8, 9]. However, factors associated with viral suppression among adolescents are not well document in lower- and middle-income countries.

Adolescents infected with HIV through high-risk behaviours have less optimal response to ART with only 24% achieving and maintaining undetectable viral loads over 3 years [10]. Although large studies of efficacy of ART in HIV-infected adults [11] and children [12] have been conducted, relatively less data has been collected describing the virologic outcomes among adolescents on ART. According to the WHO, the number of adolescents on ART continues to increase, reflecting successful treatment of perinatal infected children, infections during early adolescence, and expanding worldwide access to ART [5]. The unique behavioral characteristics of adolescents may lead to worse adherence to ART [13], which would increase their risk of both morbidity and drug resistance. As a result, measurement of virologic outcomes in this population is very critical.

Uganda ranked among the top 20 high burden countries contributing 5% of AIDS-related deaths among adolescents in 2014. The deaths were attributed to the late diagnosis and poor access to treatment with most perinatally infected children starting treatment later in life. Like other countries, Uganda committed to achieve the 90-90-90 targets by 2020; however, the country is still short on achieving the ambitious target with the third 90 scoring lowest along the cascade. In 2017, about 73% of the people living with HIV knew their HIV status; 67% were enrolled on ART; while almost 60% had achieved viral suppression. To identify people living with HIV who are likely to fail on treatment (including adolescents) and monitor their quality of life, the Uganda Ministry of Health recommended viral load testing for all people who are receiving ART for at least 6 months or more. Children under 15 years continued to have much lower rates of viral suppression compared to adults.

Although adherence to ART is important for viral suppression, some children and adolescents are sufficiently adherent but their viral loads remain high, while others have suppressed viral loads despite poor adherence. In Uganda, information on viral suppression among adolescents aged 10–19 years is limited. This is because data for adolescent aged 10–15 years is lamped up under the age desegregation of 0–14 years, while adolescents aged of 16–19 years are considered under the age desegregation of adults. It is therefore difficult to ascertain outcomes of adolescents on ART with the current data. This study aimed at assessing viral load suppression associated factors among adolescents in Kabale District.

Methods

Study design, area and population

This was both a cross-sectional and retrospective cohort study with a mixed quantitative and qualitative approaches. The study was conducted in Kabale district, Southwestern Uganda. Kabale district borders with Rubanda district in the Southwest, republic of Rwanda in the south, Rukiga district in the north and Kanungu district in the west. The district has a population of 248,700 people as per district records of June 2020. The district has three health sub districts with a total of 55 functional health facilities. The study was conducted at nine (9) public and private not for profit health facilities providing comprehensive adolescent HIV care services. The study sites were; Kabale Regional Referral Hospital, Rugarama and Rushoroza Hospitals, Kamukira, Maziba and Rubaya HC IVs, Kamuganguzi HC III, Kigezi Health Care Foundation (KIHEFO) and Buhara NGO HC III. The study was carried among HIV positive adolescents that had been on ART for at least 6 months, adolescent peers and clinicians providing adolescent HIV services at the selected health care facilities.

Inclusion and exclusion criteria

This study included HIV positive adolescents (10–19 years) that had been on ART for more than 6 months at each of the selected health facilities. Assent was sought from care takers for adolescents aged 10–17 years and informed consent for the 18–19 year olds. Both adolescent with suppressed and unsuppressed viral loads were interviewed. Additionally, key informant interviews were conducted with adolescent peers and HIV clinicians following their informed consent. This study excluded adolescents aged 10–17 years without a parent/guardian and the 18 years’ adolescents that did not consent or refused for any reason to participate in the study. Adolescents that had been transferred-in from other health facilities were also excluded because their complete clinical records could not be accessed. The study also excluded adolescent peers and HIV clinicians that did not consent and health workers that were not actively providing adolescent HIV services.

Sample size and sampling procedure

The sample size was estimated using a standard formula by [14], with 5% marginal error and 95% confidence interval to arrive at a sample size of 239 participants. The sample size was then adjusted for missing data, and non-response; adjusted sample size was computed as 252 respondents. Probability proportionate to size sampling was used in this study because of the varying ART clinic sizes. This was aimed at ensuring that adolescents from larger ART clinics had the same probability of being included in the sample as those in smaller. See Table 1.

Table 1

Proportionate sample allocation of respondents.

No.	Name of Facility	No. of active Adolescent in HIV care by end of March 2019	Proportionate Sample from each site. (x) = (a/363*252)
1	Kabale Regional Referral Hospital	187	130
2	Kamukira HC IV	46	32
3	Rugarama Hospital	41	28
4	KIHEFO	24	17
5	Kamuganguzi HC III	20	14
6	Maziba HC IV	12	8
7	Rubaya HC IV	12	8
8	Buhara NGO Health Centre III	11	8
9	Rushoroza Hospital	10	7
	Total	363	252

Because of the limited proportionate numbers especially from the small ART clinics, consecutive sampling technique was applied. All adolescents meeting the inclusion criteria were selected as they came to the clinic, until all the required number of adolescents at each health facility was achieved. Purposive sampling was used to select clinicians providing adolescent HIV services to share their views based on HIV clinical expertise while adolescent peers shared their experience of living with HIV.

Data collection

Two research assistants were recruited and trained on how to collect and fill out the data tools, obtaining informed consent and assent, and observation of all the ethical considerations. The research assistants conducted face to face interviews, extracted information from the patients’ clinical charts and also conducted the in-depth interviews with key informants. The research assistants visited the health facilities on their respective adolescent day HIV clinics and clearly explained the purpose of the study. They established rapport with the adolescents to make them comfortable and share personal sensitive information. Informed consent was obtained and interview were conducted in a private environment that ensured the adolescents’ confidentiality. It took an average of 30 minutes to complete the questionnaire. Finally, all the completed questionnaires were collected and checked for completeness.

Ethics approval and consent

The study was approved by the Institutional Ethics Committee of Bishop Stuart University. Both verbal and informed written consent was obtained from adolescents aged 18 years and above while parents/legal guardians consented for the adolescents aged 10–17 years. The adolescents were also informed that their individual medical records would be reviewed and information extracted with outmost confidentiality.

Measures

Clinical factors

In this study, secondary data on adolescent’s current viral load and retrospective clinical-related factors such as duration of ART, side effects, nutritional status and presence of comorbidities were extracted from adolescent’s clinical charts. The patient’s clinical charts have client’s data on key parameters monitored by the ministry of health including; ART regimens, viral load results, nutrition status of adolescents, ARV side effects, adherence levels, Septrin and isoniazid prophylaxis among others. In case of missing data in the clinical charts, the research assistant sought for support to triangulate data from primary tools and registers like the ART registers, dispensing logs, appointment books, viral load result forms and laboratory CD4/viral load registers.

Psychosocial factors

To assess for psychosocial factors associated with viral suppression, face-to-face interviews were conducted using semi-structured questionnaire that was adopted from the HEADS tool. The HEADS tool is a validated interview tool that is recommended by WHO and Ministry of Health for assessment, identification and management of adolescent mental health issues, take a psychosocial history as well as find local help and resources. The letters in HEADS stand for; Home, Education, Activities and peers, Drugs and Alcohol, Suicide and depression. This tool assesses for enrollment in any support group, access to housing and food, availability of parents, disclosure of HIV sero-status, substance abuse, employment, structural barriers; clinic fees, transport costs, distance from clinic, clinic waiting time, attitude of clinic staff and religious and cultural beliefs on HIV and ART. It also explores behavioral issues, assesses for depression, presence of support systems including friends or partner.

A score of 0, 1, or 2 is assigned for each psychosocial variable and these scores are summed to obtain a total score. A higher overall score on this screening tool translates into an indication of a greater need of immediate action. The HEADS tool was found to have a sensitivity of 82% and a specificity of 87% during a Rapid Mental Health Screening Tool for Pediatric Patients in the Emergency Department [15].

Adherence factors

The information on adherence factors was collected through a face to face interview questionnaire with the adolescents. The information collected included; if the adolescents were taking the ARVs, person picking the ARV refills, ARV regimens, number of pills taken per day and frequency, storage of ARVs and whether the adolescent was taking the ARVs from school or home.

Qualitative data

For qualitative data, in depth interviews were conducted with 10 key informants. The key informants included; six health workers that were purposively sampled among clinical officers and nursing officers that were active in provision of adolescent HIV services. Four adolescent peers living with HIV and on ART were also interviewed. The health workers were selected to provide and share their expert views and experience in providing HIV services for adolescent living with HIV while adolescent peers were interviewed to share their life experience dealing with HIV and taking lifelong ART. The interviews ended once saturation was achieved for each category. The research assistant sought consent from the key informant to allow audio recording during the discussion process. Recordings were then transferred and saved on a computer for transcription and analysis. Table 2 provides the details for the key informants.

Table 2

Participants for in-depth interviews.

Health Facility	No. of Key Informants	Cadre	Sex	Age in years
Kabale Regional Referral Hospital	4	Senior Clinical Officer	Male	44
		Clinical Officer	Female	38
		Adolescent Peer	Male	15
		Adolescent Peer	Male	18
Rugarama Hospital	2	Nursing Officer	Female	52
		Adolescent Peer	Female	17
Kamukira HC IV	2	Enrolled Nurse	Female	38
		Adolescent Peer	Male	18
Rubaya HC IV	1	Counselor	Female	26
Kamuganguzi HC III	1	Clinical Officer	Female	34
Total	10

Data analysis

Quantitative analysis

The quantitative data was cleaned, edited, coded and entered into the computer using Epi Data and then exported to STATA v14 for analysis. Continuous variables such as age were categorized accordingly [16] and proportions and percentages were used for categorical variables. Analysis was conducted at three levels; univariate, bivariate and multivariate levels. Bivariate analysis was conducted to determine association between viral load suppression and independent variables. Odds Ratios (ORs) were used for statistical associations at 95% confidence interval considering statistical significance for p-values less than 0.05.

Qualitative analysis

The audio recordings from key informants were listened to carefully and transcribed, and to verify the quality of transcription, the tapes were double transcribed. The data was analyzed by grouping related responses into themes and subthemes in accordance with the study objectives. Key statements were quoted verbatim to give the exact meaning using the narrative qualitative analysis approach [17].

Results

Participants demographic characteristics

Results indicate that overall, majority (67.5%) of the respondents were aged 15–19. There was almost an equal proportional allocation for both male (124) and females (125). A large proportion (98.8%) were found to have been single with only 1.2% combined proportion falling within other marital status categories. Most (52.2%) respondents had attained at least primary school level of education followed by secondary at 40.2% with the least proportion being tertiary (3. 2%). Majority of the teenagers (95.2%) interviewed were unemployed. Table 3 shows the respondent background characteristic for overall and when disaggregated by gender.

Table 3

Participants demographic characteristics segregated by gender (n = 249).

Socio-Demographic variables	Overall	Males	Females
	n(%)	n(%)	n(%)
Age Category
10–14	81 (32.5)	41 (33.1)	40 (32.0)
15–19	168 (67.5)	83 (66.9)	85 (68.0)
Marital status
Single	246 (98.8)	124 (100.0)	122 (97.6)
Married	2 (0.8)	0 (0.0)	2 (1.6)
Divorced/Separated	1 (0.4)	0 (0.0)	1 (0.8)
Level of education
None	11 (4.4)	3 (2.4)	8 (6.4)
Primary	130 (52.2)	65 (54.0)	63 (50.4)
Secondary	100 (40.2)	50 (41.2)	49 (39.2)
Tertiary	8 (3.2)	3 (2.4)	5 (4.0)
Occupation
Unemployed	237 (95.2)	119 (96.0)	118 (94.4)
Peasant	11 (4.4)	5 (4.0)	6 (4.8)
Salary earner	1 (0.4)	0 (0.0)	1 (1.0)

Proportion of adolescents who attained HIV viral load suppression

Overall, majority (81%) of the respondents had attained Viral Load Suppression (< 1000copies/ml) at the time of the interview. Fig 1 shows the proportion of adolescents who attained Viral Load suppression.

Fig 1

Proportion of adolescents who attained viral load suppression.

Clinical factors associated with HIV viral load suppression among adolescents

Results in Table 4, indicate that majority (87.1%) of the respondents who had a viral load suppression were taking ARVs for a period of five (5) years and above whereas for patients who had been on ARVs for a period of six (6) months to one (1) year, all had a suppressed viral load. Results show that having no severe opportunistic infections was associated with viral load suppression among adolescents (OR = 1.09; 95% CI [0.753–1.589]; p < 0.001). In addition, adolescents who were previously on second line ARV regimen were more likely to have viral suppression (OR = 1.83; 95%CI [1.276–4.520]; p = 0.004). More so, not having been diagnosed with malnutrition was significantly associated with viral load suppression among adolescents (OR = 0.88; 95%CI [2.574–9.335]; p = 0.037). Furthermore, adolescents who were taking Septrin were significantly associated with viral load suppression (OR = 0.75; 95%CI [2.466–8.211]; p = 0.007).

Table 4

The association between clinical factors and viral load suppression.

Variable	Viral Load Suppression		COR (95% C.I)	P-value
	Yes	No
	n(%)	n(%)
Patient period on ARVs
6 months to 1yr	7(3.4)	0(0.0)	1.7 (0.99–2.92)	0.447
Greater than 1 to less than 3 yrs.	8(4.0)	3(6.3)
Three yrs. to less than five yrs.	11(5.5)	4(8.3)
Five years and above	175(87.1)	41(85.4)
Severe opportunistic infection
Yes	8(4.0)	10(20.4)	1.09 (1.753–5.589)	0.000
No	194(96.0)	39(79.6)
Current ARV regimen
1st line	179(89.1)	42(85.7)	1.90 (0.574–6.286)	0.480
2nd line	22(10.9)	8(14.3)
Previous ARV regimen
1st line	44(21.8)	20(40.8)	1.83 (1.276–4.520)	0.004
2nd line	158(78.2)	29(59.2)
Experience of side effects
Yes	8(4.0)	5(10.4)	2.01 (1.391–2.915)	0.072
No	193(96.0)	43(89.6)
Ever had treatment interruption
Yes	7(3.5)	13(26.5)	0.86 (2.414–3.790)	0.000
No	195(96.5)	35(73.5)
Diagnosed with malnutrition
Yes	0(0.0)	3(6.1)	0.88 (2.574–9.335)	0.037
No	202(100.0)	46(93.9)
Adolescent taking Septrin/Cotrimoxazole
Yes	150(74.3)	44(89.8)	0.75 (2.466–8.211)	0.007
No	52(25.7)	4(10.2)
Other medications including local herbs
Yes	1(0.5)	0(0.0)	1.48 (0.667–3.264)	0.624
No	200(99.5)	48(100.0)

Correlation is significant at, *p <0 .05

COR is crude odds ratio

Psychosocial factors associated with HIV viral load suppression among adolescents

Results on the psychosocial factors associated with viral load suppression among adolescents found out that belonging to a support group (OR = 1.01; 95%CI [1.53–4.88]; P = 0.020), having parents alive (OR = 2.04; 95%C.I [1.02–4.12; P = 0.047]) and having meals in a day (OR = 5.68; 95%C.I [2.38–6.12]; P = 0.010), were significantly associated with viral load suppression. Other factors such as having other family members living with HIV, patient and/or caregiver disclosed about HIV status, attending school, having friends/Partner, being sexually active, use of drugs, payment of any fee for receiving health services, distance for this facility to your home, missing attending the clinic due to lack of transport and health workers handling attitude were all insignificantly associated with viral load suppression. Details on this refer to Table 5.

Table 5

Psychosocial factors associated with viral load suppression among adolescents.

Variable	Viral Load Suppression
	Yes	No	COR (95% C.I)	P-Value
	n(%)	n(%)
Belong to any support group			1
Yes	181(90.0)	41(85.4)	1.01(1.53–4.88)	0.020
No	20(10.0)	7(14.6)
Your parents alive			1
Yes	90(44.8)	20(41.7)	2.04(1.02–4.12)	0.047
No	111(55.2)	28(58.3)
Other family members living with HIV			1
Yes	160(79.6)	33(68.8)	1.84(0.99–3.43)	0.106
No	41(20.4)	15(31.2)
Patient and/or caregiver disclosed about HIV status			1
Yes	198(98.5)	48(100.0)	0.97(0.38–6.12)	0.615
No	3(1.5)	0(0.0)
Meals had in a day			1
Misses all meals in some days	6(3.0)	1(2.0)	5.68(2.38–6.12)	0.010
One	11(5.4)	7(14.6)
Two	129(64.2)	31(64.6)
More than two	55(27.4)	9(18.8)
Attend School			1
Yes	180(90.0)	45(93.8)	0.78(0.36–8.21)	0.280
No	21(10.0)	3(6.2)
Have friends/Partner			1
Yes	39(19.4)	13(27.0)	1.38(1.09–6.82)	0.240
No	162(80.6)	35(73.0)
Sexually active			1
Yes	36(17.9)	13(27.1)	2.06(0.87–7.81)	0.151
No	165(82.1)	35(72.9)
Use drugs/smokes/alcohol			1
Yes	9(4.5)	7(14.3)	6.58(0.09–6.82)	0.070
No	192(95.5)	41(85.7)
Pay any fee for receiving health services			1	0.067
Yes	0(0.0)	2(4.1)	8.44(0.87–8.81)
No	202(100.0)	47(95.9)
Distance for this facility to your home			1	0.859
0–14	108(53.7)	26(54.2)	0.40(0.17–4.45)
15–29	69(34.3)	16(33.3)
30–44	22(11.0)	5(10.4)
45–59	0(0.0)	0(0.0)
60+	2(1.0)	1(2.1)
Sometimes miss attending the clinic due to lack of transport				0.067
Yes	105(52.2)	18(37.5)	3.37(0.87–7.81)
No	96(47.8)	30(62.5)	1
Health workers treat/handle you well				0.185
Yes	196(97.5)	45(93.7)	1.1 (0.6–2.2)
No	5(2.5)	3(6.3)	1

Qualitative findings

Qualitative data gathered through interviews was thematically analyzed using thematic content analysis. See Table 6.

Table 6

Qualitative results on psychosocial factors associated with viral load suppression among adolescents.

Themes	Sub themes	Categories
Support from significant others	Family support	• Accompaniment to clinic
		• Reminder to take medicine
	Support from peers	• Showing unconditional love
		• Belonging to support group
Care availability	Access to health facility	• Walking long distance
		• Lack of transport
		• Negative treatment from health workers
	Nutritional care	• Lack of access to food and poor feeding
Mental health	Depression	• Feeling depressed
		• Burden of taking daily pills
	Disclosure	• Fear for disclosure

Findings on the psychosocial factors associated with HIV viral load suppression among adolescents found out that support from significant others like family and peers, availability of care and mental health are among the psychosocial factors that determine viral suppression among adolescents.

Theme I: Support from significant others

We found out that support from significant others like family members and peers has a significant impact on viral load suppression. This was categorized in form of family support and peer support as presented herein;

Family support

The study found out that a family offers accompaniment to the clinic and reminder to take medicine which is important in enhancing adherence to ART among adolescents.

Accompaniment to clinic. Accompaniment to clinic was found to be important in viral load suppression since it contributes much to drug adherence among adolescents on ART. This is supported by the views from one of the clinical officers who had this to say;

“A child who has someone to accompany him or her on clinic days, stands higher chances of adhering to drugs. This is important on viral load suppression as such a child is less likely to have problems with adherence and the possibility of skipping the days are very minimal.” (A 38-year-old female clinical officer).

Reminder to take the medicine. Due to pill burden, most adolescents find themselves with a challenge of skipping the medicine on some days. Getting constant reminders from family members enhances adherence leading to viral load suppression. This is in line with interview finding in which one of the participants was quoted saying;

“Taking medicine every other evening is a burden, at times you forget and recall in the morning. If you have someone to remind you, it becomes easier. But this is difficult at school, since we don’t want other kids to learn about it.” (A 15-year-old male adolescent peer)

Support from peers

From the interviews, we found out that support from peers especially receiving unconditional love and belonging to a support group are important in viral load suppression.

Showing unconditional love. We found out that getting unconditional love from peers and friends is very important for adolescents on ART. It keeps them psychologically positive which enables them to adhere to drugs. This is supported by one of the adolescent peers who had this to say;

“When you have a challenge like the one we are going through and you get someone to share it with, you feel relieved. I have two friends whom always share about the future and I feel loved. I don’t take anything for granted.” (An 18-year-old male adolescent peer)

Belonging to a support group. It was further found out that belonging to a peer support group also has advantage towards viral load suppression. This is supported by views from one of the participants who had this to say; “We make sure that there are adolescent peers so that those with psychosocial support issues can be linked to the peers for treatment support. We are introducing psychosocial aerial club activities so that they get involved in them whenever they come for their drug refills. This will help us to improve adherence, retention and viral load suppression.” (A 44-year old Male Clinical Officer).

Theme II: Care availability

Availability to care was found to be another factor affecting viral load suppression among adolescents. This was categorized into access to health facility and nutritional care main factors related to viral load suppression.

Access to health facility

From our interviews, we found out that access to health facility has a lot impact on viral load suppression among adolescents. This was categorized into walking long distances, lack of transport and treatment from health workers.

Walking distances. This view is elaborated by the views from one of the participants who had this to say;

“We have a challenge of school going adolescents who are fond of skipping appoints even to the extent of defaulting treatment. When we share with most of them we realize that the challenge of walking long distances has a hand in it. Eventually this compromises viral load suppression.” (A 52-year females Nursing Officer).

Lack of transport. We found out that lack of transport to health facilities contributes to challenges in care and eventually viral load suppression. This is confirmed by the views from one of the participants who had this to say;

The distance to home to the health facility is far and you to have transport money all the time. Besides, I don’t normally stay from one place, I keep moving from one place to another. This makes me skip my appointment days even when it is not intended.” (A 17-year-old female adolescent peer)

Negative treatment from health workers. Results further show that adolescents felt unwelcome at the health facilities because some of the health workers made adolescents uncomfortable in getting care and treatment. This is supported by the views from one of the nursing officers who had this to say; “Some of us health workers, behave unprofessionally. This scares away some of these adolescents and they field unwelcome at the health facility. They therefore begin the behaviors of defaulting treatment which compromises viral load suppression.” (A 38-year-old female nursing officer).

Nutritional care

Nutrition is important in the life of people living with HIV/AIDS, in an event of poor nutrition, this can compromise their care and treatment. We found out that lack access to food and poor feeding is one of the issues compromising viral load suppression among adolescents.

Lack access to food and poor feeding. Lack of access to food and poor feeding was found out in this study among the factors compromising viral load suppression among adolescents. This is expressed by one of the participants who had this to say;

“… this medicine that we swallow, one of the [things] you are instructed [is] that you must eat thirty minutes before you take that drug. But then you find in that time, most times, there is nothing to eat, and so what do you do before you start, before you swallow medicine, and yet your time has approached? That also is a challenge we face as youth.” (An 18-year-old male peer)

Theme III: Mental health

We found out that mental health status of adolescents has a strong influence on viral load suppression. This was categorized into depression and disclosure on the side of these adolescents.

Depression

From the interviews, we found out that feelings of depression have an influence on adherence to drugs and eventually viral load suppression. This was categorized into feeling depressed and the burden of taking daily pills.

Feeling depressed. Results show that feeling depressed affects adolescents’ adherence levels and this greatly compromises their capacity to suppress the viral load. This is supplemented by views from one of the nursing officers who had this to say;

“By default, patients on ART should be mentally positive, anything that disorganizes them mentally, compromises adherence and viral load suppression. We have a challenge where by most adolescents present with high levels of depressive symptoms.” (A 44-year-old Male Clinical Officer)

Burden of taking daily pills. It was found out that taking drugs on a daily basis is a burden to most of these adolescents and they end up not swallowing them on time. This is confirmed by one of the participants who had this to say; “You know, it is not easy packing drugs all the time, you find yourself where you have gone somewhere and time has caught you there. If there was any chance of having a drug you can swallow at least once in a week….” (An 18-year-old adolescent peer).

Disclosure

From the study, we found out that disclosure is another challenge affecting viral suppression among adolescents. While hiding to taking the drugs and trying to conceal their condition, they end up defaulting treatment.

Fear for disclosure. We found out that most adolescents have a tendency of concealing their status against their peers and significant people in their lives. This greatly affects their adherence and eventually viral load suppression. This is confirmed by the views from the participants herein;

“If you swallow these drugs where there are people; like me, there is a lady who went on telling everyone that am positive, I don’t know how she got to know but finally the people around me started isolating me that I will infect them. So, the people around us make us isolate ourselves.” (An 18-year-old male peer)

Discussion

Proportion of adolescents on ART achieving virologic suppression

This study found that 81% of the HIV positive adolescents had achieved viral suppression. This is in line with a study conducted in South Africa which found an 81% viral load suppression among adolescents [18]. Furthermore, [19] found an 83% viral load suppression among adolescents in India. The viral suppression rate in this study is higher than that of a study done in Kenya which reported a 59% viral suppression among HIV positive adolescents [20]. In addition, a study done in South Africa found a viral suppression rate of 65.1% among adolescents [21]. Similarly, a 62.5% proportion of adolescents were virally suppressed in a study conducted in Tanzania [12]. Also, [22] revealed a 73.61% viral load suppression among HIV adolescents in Ethiopia. More so, a study by [23] found that 65.5% proportion of adolescents had achieved viral load suppression.

Similarly, [4] found a 76.8% proportion of adolescents who had achieved viral load suppression. This is in line with a study conducted in South Africa which found out that 76% of the adolescents had achieved viral suppression [7]. Systematic review on viral non-suppression rate in low or middle-income countries of the pooled estimate had 16% [24]. A lower viral load suppression of 23% was found among HIV positive adolescents in a study conducted in Uganda [25]. The overall viral suppression rate reported in this study is higher than the global viral suppression rate of 35% [20] and slightly lower than the 90% UNAIDS target. Similarly, a study by [26] found a 27.3% viral load suppression among adolescents in South Africa. In addition, 49% of the HIV positive adolescents in Brazil had achieved viral load suppression [12]. The disparities in viral suppression rates noted could be as a result of differences in systems for the management of HIV patients, including access to treatment, monitoring of adherence, and coverage, as well as disease surveillance in different regions [27]. The overall proportion of viral load suppression in the study conducted in Uganda was 73% among older adolescents [8].

The results though still below the recommended 90% by UNAIDS, there is noted progress towards achieving this target among adolescents in Kabale district. This improvement in viral suppression may be attributed better ART adherence preparation and follow by the counselors that have been deployed to support health facilities with the support of implementing partners like USAID RHITES-SW, engagement of adolescent peers in adolescent HIV services delivery, holiday comprehensive clinical and psychosocial clinics and ‘‘Ariel clubs”. The health workers have also been trained in provision of adolescent friendly HIV services and separate HIV clinics for adolescent established which have reduced stigma and encouraged peer-to-peer support. The ministry of health has also provided standard service packages with standard operating procedures and guidelines developed to guide quality services delivery.

Clinical factors associated with viral load suppression among adolescents

In contrast to the findings of this study, shorter duration on ART is associated with viral non-suppression, which is expected given the destruction of CD4 cells resulting from high viral replication. Although the relationship between viral non-suppression, immunological responses, and duration on ART is not always consistent [28]. The findings could be attributed to better ARV regimens with high treatment efficacy and tolerability, fixed drug combination with majority of the adolescent initiating on ART taking a single pill a day which improves adherence.

The findings are also in contrast to a South African study, which reported that adolescents who had been on ART between six and 12 months were more likely to have viral non-suppression (viral load > 400 RNA copies/mL) compared with those who had been on treatment longer [29]. Exposure to ART for a shorter duration was a common characteristic among adolescents who failed to achieve viral suppression. This finding is consistent with that reported in studies conducted in Northwest Ethiopia [30] and Swaziland [9].

The results of this study show that adolescents who were on second line ART were more than one times more likely to have their viral load suppressed. This study’s findings agree with those of a study conducted in Zimbabwe which found that those who are on second line treatment achieved viral suppression unlike those on first line treatment [19]. Studies have demonstrated that being on second line ART is an important predictor of viral suppression among adolescents [31]. Barriers to adherence should be addressed in patients with suboptimal adherence before switching to second line therapy to improve their outcome. This study did not evaluate timeliness in switching to effective ART regimens after failure though the timeliness in switching to effective ART regimens after failure may affect viral suppression. Adolescents with delayed switching from a failing ART regimen to an effective one, experience virological failure and are at an increased risk of accumulating drug resistance and mutations [32].

Furthermore, the results indicate that odds of having suppressed viral load are almost five times higher among respondents who took their ARVs compared to those who did not take their ARVs. Similarly, [33] found that good adherence to ART was positively associated with viral suppression among adolescents. More so, adolescents with good adherence were significantly more likely to exhibit virologic suppression [34]. Good adherence to the ART is crucial for successful viral suppression, as incomplete adherence leads to an increase in HIV viremia, risk of treatment failure, and accumulating resistance mutations [35]. The findings were similar to other studies that demonstrated that suboptimal adherence to ART is associated with virological failure among adolescents [23].

Similarly, [8] demonstrated that poor adherence to ART was associated with low viral suppression. In a one to one unmatched case control study conducted in Zimbabwe, poor adherence among others was an independent risk factor for virological failure [19]. Non-adherence to medications was associated with high viral load of >1000 copies/mL in an Ethiopian study [36]. Similarly, in a study describing predictors of antiretroviral treatment adherence among a diverse cohort of adolescents’ non-adherence by self-report was associated with higher viral load [37].

In addition to these studies, findings from the interviews revealed that perceived stigma, unintended disclosure and discrimination deterred the adolescents from obtaining, taking, and keeping their medications. The key informants described how the adolescents avoid going to the clinic to obtain their ART because they do not want to be seen by their peers at the clinic collecting ART medication and in so doing link them to HIV diagnosis. They further described how adolescents avoid taking pills in front of others for fear of stigma, rejection, and gossip by their peers most especially those in school. The school setting presents a unique barrier to adherence to medication for the adolescents since it not easy to leave school to keep clinic appointments for ART refill, particularly because they did not tell their teachers about their HIV status.

Psychosocial factors associated with viral load suppression among the adolescents

In this study, it was found that a substantial proportion (81.5%) who had suppressed viral loads belonged to a support group. The findings of this study concur with those of a study done in Tanzania which revealed that adolescents who belonged to peer support groups had better viral suppression outcomes [7]. More so, [38] also found that belonging to a support group was associated with viral suppression. This is because peer support groups have been identified as a successful method for improving the uptake of health services by adolescents thus facilitating ART adherence. Adolescents can be kept in care by using peer supporters and social workers who provide psychosocial support to improve ART adherence that results into viral suppression.

Surprisingly, a considerable proportion of the adolescents in this study reported being total orphans, though there was no statistical significance with viral load suppression. On the contrary, other studies found out that being single or double orphan was associated with virological failure [11, 39, 40]. This was similar to what some of the respondents reported in this study that the vulnerability of the adolescents as a result of the death of a biological parent or the lack of support from parents or guardians puts them at risk of having non-viral suppression.

In this study, although a significant number of the HIV positive adolescents had members in their family living with a positive HIV status, there was no significant relationship with viral suppression. However, some studies indicate that adolescents have been reported to have better viral outcomes when they had a person living with HIV in the same household [19, 41]. Furthermore, other studies conducted in Zimbabwe [42], Tanzania [28], and Ethiopia [23], found out that family support improves viral outcomes. Having HIV positive caregivers has been described as a facilitator for optimal adherence that leads to viral suppression [10]. Contrary to these studies, some health care workers reported that adolescents who live with people who are not HIV positive are likely to have poor viral outcomes.

In this study being aware of one’s HIV status (disclosure) was not significantly associated with viral load suppression although most of the adolescents reported having been disclosed to. There was a very small proportion of adolescents recorded to be unaware of their own HIV status and this may have affected the findings. However, a study done in South Africa found a statistically significant association between disclosure and viral suppression among HIV positive adolescents [43]. Additionally, in Zimbabwe, disclosure increased the odds of viral suppression [19], and in Nigeria disclosure of HIV status predicted a better viral suppression as a result of good adherence [44].

Disclosed adolescents have better access to social support and tend to be less depressed over the long-term, thereby adhering to their medication well hence achieving viral suppression [42]. In addition, adolescents who have been disclosed to about their own HIV‐positive status may be in a better position to access antiretroviral therapy (ART) from health facilities and psychosocial support from peer support groups which in turn translates to viral suppression [40]. However, according to a study conducted in Uganda [25], it revealed delay in disclosing HIV status to adolescents was common among the care givers and this led to non-adherence which in turn resulted into virologic failure.

Furthermore, this study showed that a significant percentage (82.4%) of the respondents that had suppressed their viral loads (< 1000copies/ml) reported not to have used drugs/smoked/ drunk alcohol. Similarly, [19] found no difference in virological suppression and use of drugs/smoke/alcohol among HIV positive adolescents. However, a study done in low middle-income countries identified that alcohol consumption and recreational drug use contributes to virological non-suppression among adolescents as a result of poor ART adherence [24]. This was also mentioned by one of the peer adolescents that some of the adolescents who indulge in alcohol intake, have their viral loads unsuppressed.

More so, it should be noted that the independent association of alcohol consumption and virological failure is not surprising since alcohol use among adolescents has been associated with lower treatment adherence, disease progression and failed viral suppression. One study by [45] examined the association of alcohol with viral suppression and found that those who consumed alcohol were more likely to develop virological failure compared to those who did not. In another study by [19], alcohol use was associated with poor adherence which directly translates into virological failure. The contradiction between this study and other studies could be explained by the levels of drinking alcohol among adolescents in the study, which had no effect on their drug adherence levels.

Study limitations

This study has a number of limitations, which should be considered while interpreting the above findings. First, due to the sampling strategy, the study only included adolescents who were currently on treatment. Adolescents who were lost to follow-up were not included, which could have resulted in overestimating the rate of viral suppression. Longitudinal follow up with multiple assessments of viral load trends may provide a better picture of virological response compared to the single latest viral load measurement used in this study. Second, the study relied on self-reported data, which may be affected by recall and social desirability bias. Third, adolescents who accessed care from low volume sites providing care to less than 10 adolescents were excluded, which may bias the results given that volume of patients is a key determinant of provider competency and patient outcomes. Finally, due to a lack of genotype data for the sample, exploration of virological failure was not possible.

Conclusions

This study finding indicate that HIV viral suppression among HIV positive adolescents on ART in Kabale district has significantly improved to 81%. However, this is still below the UNAIDS target of 90% of people on ART to be virally suppressed. The findings also indicated that severe opportunistic infection, and treatment interruptions were the major clinical factors associated with viral load non-suppression. The study also found out that support from significant others, having access to care and mental health status are highly associated with viral load suppression among the adolescents. Therefore, programs providing care to adolescents should focus on providing routine and intensive adherence counselling to prevent treatment interruptions and occurrence severe opportunistic, support disclosure and formation of adolescent peer support groups to improve viral load suppression among adolescents living with HIV.

Recommendations

The study recommends that ministries of health and education should prioritize formal recruitment of counselors into their formal staffing structures. This will ensure sustained provision of psychosocial support to adolescent living with HIV. The study also recommends integration of HIV care services and interventions into school programs through capacity building of matrons, senior women and school nurses to provide appropriate care and support services for school going HIV positive adolescents.

There should be streamlined implementation adolescent friendly services; capacity building of health workers, opening HIV clinics over the weekends and provision of multi-month ARV refills that are re-aligned with holidays to address the needs of in-school adolescents, and integrating adolescent peers in services provision. Intensive adherence counseling should be prioritized for adolescents with non-suppressed viral loads.

Further studies also need to be carried out in the whole country with a focus on lower facilities with limited technical capacity to further answer the discrepancies in viral load suppression across health facilities and districts.

(XLSX)

Click here for additional data file.

22 Oct 2021

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Siddappa N. Byrareddy, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ".

4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

Additional Editor Comments:

One of the reviewer raised substantial concerns, and therefore, I recommend authors to address carefully during the revision.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors have performed a well organized retrospective study on factors associated with HIV viral suppression among adolescents. It is highly commendable that they have considered both clinical and psycho social factors into identify the factors associated with failure of achieving the goal of UNAIDS . Authors have also concluded the manuscript with favorable recommendations towards achieving the goal.

I have some minor corrections

1. an abbreviation should be used after giving the expanded version of the same For eg HIV is abbreviated in the first line of background and then expanded in second line.

2. Authors should review for grammatical errors

Reviewer #2: The manuscript by Gordoni et al investigated the HIV viral suppression levels among adolescents in Kabale District, Uganda and determined that 81% of subjects had viral load suppression. Furthermore, the authors investigated various clinical factors in the same subjects and found that the length of ART, status of opportunistic infections, and history of second line ARV regimens or antibiotics are significantly associated with viral suppression. In addition, they found that social and nutrition support are associated with viral load suppression in adolescents. Overall, the manuscript provides viral load data on a selected group of HIV-1-infected adolescents and attempts to decipher clinical and social factors impacting the viral load suppression. However, the study is poorly designed, lacks a central hypothesis, and there are a number of concerns that need to be addressed.

Major points:

1. The study lacks a central hypothesis. If the authors set out to sample the rate of viral load suppression in adolescent in the region, then the subject selection will need to be justified to represent the general HIV-1 infected adolescent population. The current subjects are skewed toward the 15-19 age group, which is unlikely to represent the general HIV-1 infected adolescent population in the region.

2. The introduction section does not have key review of the field. At least ten similar studies have already been published and cited in the discussion section, which are related to viral suppression rates in HIV-1 infected adolescents. Furthermore, the identified clinical and social factors associated with viral load suppression are largely expected. Therefore, it is unclear how the current manuscript will provide new information of interest to the scientific community.

3. Part of written informed consent are not from parent/guardian but from care providers.

4. It is unclear how the key Odds Ratios statistical association were performed for the clinical and social factors. In Tables 4 and 5, percentages of many variables look close enough between viral suppression and unsuppression groups, yet many p values have reached the significant mark. With the modest sample size, it will be more meaningful to present data in dot pot association graphs rather than the current tables.

5. The authors is over-interpreting the association data. Psychosocial (or even general psychological factors) attributes have a correlated response to lower viral suppression because of either mismanagement of treatment or default of the regiment all together. However, the authors phrase it, making it sounds like a direct influence (as in a biological factor).

6. There are many errors in English usage and the manuscript needs to be carefully proof read.

Abstract section:  Mission preposition.  "...consecutive sampling techniques was used to select participants..."

Abstract section:  under Conclusion, they capitalized Viral when it doesn't need to be.

Background:  I'm not sure what they mean by "die owing."  Would be better to say, "die due to."  For a more technical sentence it would be more appropriate to say Adolescent's mortality is lower instead of the current vernacular.

At the end of the Background section: age disaggregation groups is an odd choice in adjective conjugation.  More appropriate to say, "This is because age groups are disaggregated into adolescents between the ages of 10-15 years..."

Last line of Sample Size and Sampling Procedures: HIV lived experiences just does not sound correct.  More appropriate to say, "...while adolescent peers shared their experience living with HIV."

Under psychosocial factors, qualitative data: They used "lived experiences" again.  It's just an odd way of saying current life experiences dealing with HIV.

Negative treatment from health workers section: This is clearly supposed to say, "...and they feel unwelcome at the health facility."

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

15 Dec 2021

Siddappa N. Byrareddy, PhD

Academic Editor

PLOS ONE

Dear Byrareddy

We are writing to express our appreciation to you and the team of reviewers for carefully reviewing our manuscript titled “Factors associated with HIV viral suppression among adolescents in Kabale district, southwestern Uganda’’ (pone-d-21-24368) and to resubmit it for consideration of publication in PLOS ONE. The reviewers identified aspects of the manuscript that required revision. We are pleased to resubmit to you a revised version of the manuscript, which incorporates changes that have strengthened the overall manuscript. In the attached rebuttal memo, we describe how we addressed each of the points that the reviewers raised.

Academic Editor; Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

Response: We thank the editor for identifying this gap. This has been addressed in the methods section. The study was approved by the Institutional Ethics Committee of Bishop Stuart University. Both verbal and informed written consent was obtained from adolescents aged 18 years and above while parents/legal guardians consented for the adolescents aged 10-17 years. The adolescents were also informed that their individual medical records would be reviewed and information extracted with outmost confidentiality.

Reviewer #1; An abbreviation should be used after giving the expanded version of the same For e.g. HIV is abbreviated in the first line of background and then expanded in second line.

Response: We thank the reviewer for identifying this error. We have reviewed and addressed the abbreviations.

Reviewer #1; Authors should review for grammatical errors.

Reviewer #2; There are many errors in English usage and the manuscript needs to be carefully proof read.

Response: We thank the reviewers for pointing out these grammatical errors. We have addressed the grammatical errors.

Reviewer #2; The study lacks a central hypothesis. If the authors set out to sample the rate of viral load suppression in adolescent in the region, then the subject selection will need to be justified to represent the general HIV-1 infected adolescent population. The current subjects are skewed toward the 15-19 age group, which is unlikely to represent the general HIV-1 infected adolescent population in the region.

Response: The study was conducted in Kabale district which is in south western Uganda. The word ‘’Kabale District’’ was missed in the title of the Manuscript. The study therefore did not assess viral load suppression in the whole south west region. The study subjects were selected from all the nine (9) sites providing adolescent HIV services in Kabale district and therefore the findings are representative of the district. At the time of the study a total of 363 adolescents were receiving HIV care in Kabale district. Sample size was estimated using a standard formula by (Kish & Leslie, 1965), with 5% marginal error and 95% confidence interval to arrive at a sample size of 239 participants which represented 65% of the total adolescents in HIV care. The sample size was then adjusted for missing data, and non-response; adjusted sample size was computed as 252 respondents. Probability proportionate to size sampling was used in this study because of the varying ART clinic sizes. This was aimed at ensuring that adolescents from larger ART clinics had the same probability of being included in the sample as those in smaller. The data was therefore not skewed towards the 15 -19 age group.

Reviewer #2; The introduction section does not have key review of the field. At least ten similar studies have already been published and cited in the discussion section, which are related to viral suppression rates in HIV-1 infected adolescents.

Response: We thank the reviewer for identifying this omission. We have revised this section to include the key review under the introduction section.

Reviewer #2; Furthermore, the identified clinical and social factors associated with viral load suppression are largely expected. Therefore, it is unclear how the current manuscript will provide new information of interest to the scientific community.

Response: We thank the reviewer for this important question. Although we acknowledge that the findings were largely expected, not many studies have been done to find out the HIV viral associated factors among adolescent especially in the rural settings and specifically in Kabale district. These findings will also provide age specific HIV viral load suppression rates which the routinely collected HIV program data does not provide and therefore will inform designing age specific interventions. The findings will also inform the Kabale district health department on their progress on the attainment of the 90:90:90 UNAIDS target.

Reviewer #2; Part of written informed consent are not from parent/guardian but from care providers.

Response: We thank the reviewer for identifying this. This was a wrong choice of word ‘’caregivers’’ informed consent was actually sought from the parents and guardians. We have made the corrections to use parents/guardians. e.g. ‘’ ……. parents/legal guardians consented for the adolescents aged 10-17 years’’.

Reviewer #2; It is unclear how the key Odds Ratios statistical association were performed for the clinical and social factors. In Tables 4 and 5, percentages of many variables look close enough between viral suppression and suppression groups, yet many p values have reached the significant mark. With the modest sample size, it will be more meaningful to present data in dot pot association graphs rather than the current tables.

Response: Thank you for pointing this out. It would have been interesting to explore this aspect of analysis. However, in the case of our study, we believe that it would be more appropriate to use logistic regression to generate the odds ratios at bivariate to see the relationship that exists between two variables, and multivariate to see if any, are correlated with the outcome variable than the dot plot. Furthermore, multivariate logistic regression model was used to estimate factors associated with viral load suppression adjusting for potential confounders. The multivariate logistic regression model employed a backward step wise analysis to include all the variables in the model with p< 0.05 in selecting the final model. Considering our sample size, the authors think the dot plot will become overcrowded, making it difficult to read since the points may become cluttered. In addition, a dot plot is best when the sample size is less than approximately 50. The goal in this case was to determine which variables influence or cause the outcome.

Reviewer #2; The authors is over-interpreting the association data. Psychosocial (or even general psychological factors) attributes have a correlated response to lower viral suppression because of either mismanagement of treatment or default of the regiment all together. However, the authors phrase it, making it sounds like a direct influence (as in a biological factor).

Response: We thank the reviewer for this excellent suggestion. The authors think the psychosocial mechanisms may influence retention and adherence to treatment since issues like stress, traumatic events, and depression can lead to decreased CD4 counts and increased viral load, and therefore, accelerate HIV disease progression. In addition to the biological mechanisms that link HIV and psychological factors, social factors contribute to poor mental health outcomes among adolescents living with HIV. Because, the psychosocial problems can adversely affect adherence to ART and may lead to poor HIV treatment outcomes, the country opted for routine psychosocial factors screening as part of adherence support.

Reviewer #2; Abstract section: under Conclusion, they capitalized Viral when it doesn't need to be.

Response: We thank the reviewer for pointing out this error. We have edited the sentence ‘’ …. findings indicate that HIV viral suppression among HIV positive adolescents ……’’

Reviewer #2 Background: I'm not sure what they mean by "die owing." Would be better to say, "die due to." For a more technical sentence it would be more appropriate to say Adolescent's mortality is lower instead of the current vernacular.

Response: We thank the reviewer for suggesting a more technical sentence. There is no doubt that use of technical terms will strengthen our paper. We have rephrased the sentences to read ‘’ The mortality of adolescents living with HIV due to acquired immune deficiency syndrome (AIDS)-related causes is higher than in adults (UNICEF, 2018)’’.

Reviewer #2 At the end of the Background section: age disaggregation groups is an odd choice in adjective conjugation. More appropriate to say, "This is because age groups are disaggregated into adolescents between the ages of 10-15 years..."

Response: We thank the reviewer for providing this guidance. We have edited the sentence to read;’’ This is because data for adolescent aged 10–15 years is lumped up under the age desegregation of 0–14 years’’

Reviewer #2 Last line of Sample Size and Sampling Procedures: HIV lived experiences just does not sound correct. More appropriate to say, "...while adolescent peers shared their experience living with HIV."

Response: We thank the reviewer for this correction. We have edited the sentence to read; …….’’ while adolescent peers shared their experience of living with HIV’’."

Reviewer #2 Under psychosocial factors, qualitative data: They used "lived experiences" again. It's just an odd way of saying current life experiences dealing with HIV.

Response: We again thank the reviewer for this correction. We have made the correction … ‘’while adolescent peers were interviewed to share their life experience dealing with HIV and taking lifelong ART’’.

Reviewer #2 Negative treatment from health workers section: This is clearly supposed to say, "...and they feel unwelcome at the health facility."

Response: We thank the reviewer for pointing out this concern. We have revised the text for the sentence to read as follows; ….’’ Results further show that adolescents felt unwelcome at the health facilities because some of the health workers made adolescents uncomfortable in getting care and treatment.

Thank you for your time. We believe these revisions have resulted in a significantly improved manuscript.

We look forward to hearing from you in the due time regarding our submission and to respond to any further questions and comments you may have.

Sincerely,

Tugume Gordon Peterson.

Submitted filename: Response to Reviewers.doc

Click here for additional data file.

10 May 2022

Submitted filename: comments-PLoS ONE-1.docx

Click here for additional data file.

17 May 2022

Reviewer #2; Second paragraph of Background section: “Two recent studies from southern Africa reported that HIV positive adolescents had worse outcomes in terms of virological suppression and rates of virological failure.” Worse as compared to? Also the two citations?

Response: We thank the reviewer for pointing out this omission. We have removed this statement since there is no comparison that was stated.

Reviewer #2; Third paragraph of Result section. Data in this paragraph are from Table 4, but there is no reference of Table 4 in the text.

Response: We thank the reviewer for identifying this omission. We have referenced table 4 in the text.

Reviewer #2; Fourth paragraph of Result section: “associated to” should be “associated with”.

Response: We thank the reviewer for this correction. We have edited the sentence to read; ……. “associated with’’…

Reviewer #2; Qualitative findings section: “on the on”, please remove the second “on”.

Response: We again thank the reviewer for this correction. We have made the correction and removed the second ‘’on’’ for the sentence to read ‘’…. findings on the psychosocial factors associated with….

Reviewer #2; Theme I: Support from significant others section: It is unclear why the authors discussed significant others when 98.8% of the subjects were single. Furthermore, there is no specific data from Tables 5 and 6 showing that having significant others increases viral load suppression.

Response: We thank the reviewer for raising this critical issue. We appreciate that most significant others are persons who are important to one's well-being especially spouses or one in a similar relationship. However, in this study we also included guardian, family members and others persons including peers who provided support to adolescent including accompanying them to the clinics and provided reminders to take medicine which was important in enhancing adherence to ART.

Submitted filename: Response to Reviewers.doc

Click here for additional data file.

20 Jun 2022

FACTORS ASSOCIATED WITH HIV VIRAL SUPPRESSION AMONG ADOLESCENTS IN KABALE DISTRICT, SOUTHWESTERN UGANDA.

PONE-D-21-24368R2

Dear Dr. Gordon,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Siddappa N. Byrareddy, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

8 Aug 2022

PONE-D-21-24368R2

Factors associated with HIV viral suppression among adolescents in Kabale District, South Western Uganda.

Dear Dr. Gordon:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Siddappa N. Byrareddy

Academic Editor

PLOS ONE